SUBSEQUENT EVENTS	9 Months Ended
Jun. 30, 2025
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 12 - SUBSEQUENT EVENTS On August 27, 2025, the Company transferred 100,000 shares of RM stock in satisfaction of $100,000 of principal of convertible notes. From September 8, 2024, through October 28, 2025, the Company sold 822,337 shares of the RM stock it owned for $625,500. On October 14, 2025, the Company agreed to transfer, and 2 individuals agreed to accept 150,000 shares of RM stock in the aggregate, in satisfaction of shares of Company common stock the Company owed to the individuals. On October 15, 2025, the Company issued 10,000,000 shares of common stock, valued at $220,000 ($0.022 per share, the market price on the date of the agreement) to an existing shareholder, pursuant to a consulting agreement. The Company has evaluated subsequent events through the date the financial statements were issued. The Company has determined that there are no other such events that warrant disclosure or recognition in the financial statements.

SUBSEQUENT EVENTS

9 Months Ended

Jun. 30, 2025

NOTE 12 - SUBSEQUENT EVENTS

On August 27, 2025, the Company transferred 100,000 shares of RM stock in satisfaction of $100,000 of principal of convertible notes.

From September 8, 2024, through October 28, 2025, the Company sold 822,337 shares of the RM stock it owned for $625,500.

On October 14, 2025, the Company agreed to transfer, and 2 individuals agreed to accept 150,000 shares of RM stock in the aggregate, in satisfaction of shares of Company common stock the Company owed to the individuals.

On October 15, 2025, the Company issued 10,000,000 shares of common stock, valued at $220,000 ($0.022 per share, the market price on the date of the agreement) to an existing shareholder, pursuant to a consulting agreement.

The Company has evaluated subsequent events through the date the financial statements were issued. The Company has determined that there are no other such events that warrant disclosure or recognition in the financial statements.

CYTTA CORP. 10-Q